A record 14.1 million Americans signed up for health insurance since the start of the 2022 open enrollment period in November 2021, the U.S. health department said on January 13.
The U.S. Supreme Court on June 21 declined to hear a bid by health insurance companies to seek a full reimbursement from the federal government under a provision of the Obamacare law aimed at encouraging them to offer medical coverage to uninsured Americans.
One million Americans signed up for health insurance on the U.S. government website Healthcare.gov during a special enrollment period that began on Feb. 15, President Joe Biden said in a statement on May 11.
U.S. President Joe Biden will reopen the nation’s online health insurance marketplace for people who cannot obtain coverage through their employers, the White House said.
U.S. Supreme Court justices signaled they are unlikely to strike down the Obamacare healthcare law in a legal challenge brought by Texas and 17 other Republican-governed states and joined by President Donald Trump’s administration.
Premiums for an average health insurance plan under the Affordable Care Act dropped by 2% for the 2021 coverage year, according to a report released by the Trump administration, which is seeking to invalidate the 2010 healthcare law.
The U.S. Supreme Court rejected a bid by the Democratic-controlled House of Representatives and 20 Democratic-led states to fast-track consideration of their appeal seeking a definitive ruling that the Obamacare healthcare law does not violate the U.S. Constitution.
The U.S. Supreme Court agreed to decide whether the federal government must pay insurers $12 billion under an Obamacare program aimed at encouraging them to cover previously uninsured people after the healthcare law was enacted in 2010.
Enrollments in healthcare plans for 2019 through the Federal Obamacare marketplace dropped marginally by 300,000 from 2018, according to U.S. government figures.
Whatever comes out of Congress on the “repeal and replace” of the Affordable Care Act (ACA or Obamacare) matters because it will affect the bottom line of the life sciences industry as well as all of its industry partners.
